News
November 9, 2018
Antiva’s Gail Maderis Finds Inspiration in Today’s Biotech Innovation Read article (BioSpace)
November 8, 2018
San Francisco Business Times Names Gail Maderis One of 2018’s Most Admired CEOs Read article (SF Business Times)
August 16, 2018
A Women’s Health Startup Tried to Drum Up Interest for a Much-Needed Drug. Many Men Didn’t Get It Read article (STAT)
July 10, 2018
Antiva Biosciences Closes $15 Million Series C-1 Financing Read more
March 28, 2017
Antiva Biosciences Closes $22 Million Series C Financing Read more
August 6, 2015
Antiva Biosciences Raises $16 Million Series B Financing to Advance Lead Compound for Human Papillomavirus Infections Read more
August 6, 2015
With $16M Series B, Antiva Hopes to Kill Cancer-Causing HPV Read article (Xconomy)
August 6, 2015
Why a longtime biotech exec shunned retirement for a 'breakthrough' Read article (SF Business Journal)
